Pharmaceuticals
11:08 pm
Thu August 22, 2013

New Hope for Alzheimer's Disease Drug

TransTech Pharma drug aimed at delaying onset of Alzheimer's disease is headed toward phase 3 testing.
Credit epSos vis flickr

The incidence of the mysterious and devastating Alzheimer's disease continues to rise in the U-S.  Justin Catanoso, Business Journal contributing writer and director of Wake Forest University's journalism program,  discusses a Triad company's new drug with potential to delay the onset of Alzheimer's.

A new Alzheimer's drug from a Triad pharmaceutical company is making its way toward phase 3 testing.

Related program: